Navigation Links
Cancer cells show rewired, fragmented microRNA networks
Date:5/3/2010

COLUMBUS, Ohio A new study shows that a family of molecules called microRNA work together in single, well-connected networks to control many important functions in healthy cells, but that in cancer cells the networks are rewired and fragmented.

The research, led by scientists at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in collaboration with investigators at 11 other centers, introduces a new way of discovering cancer genes and identifies new miRNAs that can be used as targets for drug development and pinpoints possible new cancer-related proteins, says study leader Dr. Carlo Croce, professor of molecular virology, immunology and medical genetics, and director of Ohio State's Human Cancer Genetics program.

MicroRNA (miRNA) are tiny molecules discovered 10 years ago that control important cell functions, including growth, proliferation and differentiation. Abnormal miRNA activity plays an important role in cancer development.

The new study, published in the May 3 issue of the journal Genome Research, shows that the miRNA network in healthy cells, when mapped, resembles a family tree with dozens to hundreds of members. Each cell type has its own specific network, with particular miRNAs playing a more central role and serving as hubs within the network.

In cancer cells, however, the single network is replaced by subnetworks that usually include small detached clusters of two to six miRNAs.

"The presence of these small groups that exist outside the main network was completely unexpected," Croce says. "Some of these miRNA outliers are well known cancer genes, while the involvement of others in cancer was unknown."

Previous studies have measured differences in individual miRNA levels between cancer and normal tissues, says first author Stefano Volinia, assistant professor of biomedical informatics and of molecular virology, immunology and medical genetics.

"The molecules were always considered individually and, generally, unrelated to each other, because we did not know much about how miRNAs cooperate," Volinia notes. "In this study we show that key cancer genes can be identified on the basis of their relationships, rather than on their overactivity or loss."

To complete this study, the researchers studied miRNA expression profiles in 3,300 human cancer samples and 1,100 healthy tissue samples. These samples represented 50 different normal tissues and 51 cancer types, 31 of which were solid tumors and 20 leukemias and lymphomas.

"The size of our database enabled us to analyze coordinated miRNA activities and to build miRNA networks for different solid tumors and leukemias," Croce says.

In lung cancer, for example, the study mapped a subnetwork of 16 miRNAs plus eight groups of two or six miRNAs that are detached from the larger subnet. Lung cancer and other solid tumors showed more of these detached groups than did leukemias.

"Our findings suggest that we should reconsidered miRNA activity in cancer as the cooperative work of small groups of rebellious genes," Volina says.


'/>"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Related medicine news :

1. Targeted therapy prolongs life in patients with HER2-positive breast cancer
2. New Drugs, New Combinations Fight Breast Cancer
3. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
4. MDS Nordions TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers
5. National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis
6. Panel calls for reducing colorectal cancer deaths by striking down barriers to screening
7. Lung Cancer: Large Impact, Little Funding
8. Inflammation marker related to obesity is elevated in patients with pancreatic cancer
9. Prolactin blocks oncogene associated with poor prognosis in breast cancer
10. Older female cancer survivors have added health issues compared to their counterparts
11. Definitive study confirms chemo benefit in postmenopausal breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology: